Tech Center 1600 • Art Units: 1682
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17921710 | DETECTING PANCREATIC NEUROENDOCRINE TUMORS | Final Rejection | Mayo Foundation for Medical Education and Research |
| 17668915 | MATERIALS AND METHODS FOR DETERMINING CANCER RISK | Final Rejection | Mayo Foundation for Medical Education and Research |
| 17640740 | DETECTION OF CHLAMYDIA TRACHOMATIS NUCLEIC ACID VARIANTS | Non-Final OA | Gen-Probe Incorporated |
| 18246456 | METHOD FOR PREDICTING IMMUNOTHERAPY RESISTANCE | Non-Final OA | KONINKLIJKE PHILIPS N.V. |
| 18298922 | TRANSMEMBRANE NANOSENSOR ARRAYS FOR RAPID, ULTRA-SENSITIVE AND SPECIFIC DIGITAL QUANTIFICATION OF INTERNAL MICRO-RNA CONTENT OF INTACT EXOSOMES | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17793382 | COMPOSITIONS AND METHODS FOR DETECTION OF OVARIAN CANCER | Final Rejection | Mercy BioAnalytics, Inc. |
| 18323143 | Double-Stranded DNA Deaminases and Uses Thereof | Non-Final OA | New England Biolabs, Inc. |
| 17780926 | UPPER URINARY TRACT UROTHELIAL CARCINOMA IDENTIFICATION METHOD | Final Rejection | KEIO UNIVERSITY |
| 18006888 | BIOMARKERS FOR DIAGNOSING AND MONITORING LUNG CANCER | Non-Final OA | SORBONNE UNIVERSITE |
| 18075729 | METHODS, COMPOSITIONS, AND KITS FOR DETECTING ALLELIC VARIANTS | Non-Final OA | LIFE TECHNOLOGIES CORPORATION |
| 17760652 | HUMAN MITOCHONDRIAL DNA SEQUENCING BY TARGETED AMPLIFICATION OF MULTIPLEX PROBES (MTDNA-STAMP) | Final Rejection | CORNELL UNIVERSITY |
| 17384241 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Final Rejection | GRAIL, LLC |
| 17890694 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING SUBJECTS AT RISK OF POOR CANCER SURVIVAL | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 17632783 | CANCER DETECTION AND CLASSIFICATION | Final Rejection | The United States of America, as represented by the Secretary, Department of Health and Human Servic |
| 18450653 | KIT FOR IDENTIFYING TUMOR TISSUE-OF-ORIGIN AND DATA ANALYSIS METHOD | Non-Final OA | Hangzhou ShengTing Medical Technology Ltd. |
| 18253582 | METHOD FOR ISOLATING NUCLEIC ACID USING BINDING BUFFER INCLUDING COMPOUND HAVING LOW OR INTERMEDIATE DIELECTRIC CONSTANT | Non-Final OA | BIONEER CORPORATION |
| 18255113 | METHOD FOR PREIMPLANTATION GENETIC SCREENING OF EMBRYOS | Non-Final OA | REPROBIOGEN INC. |
| 18254179 | Ribosomal profiling in single cells | Non-Final OA | Koninklijke Nederlandse Akademie van Wetenschappen |
| 17716395 | CELL-FREE DNA METHYLATION AND NUCLEASE-MEDIATED FRAGMENTATION | Final Rejection | GRAIL, Inc. |
| 17980271 | Purified Enriched Population Exosomes Derived From Individuals With A Chronic Progressive Lung Disease For Noninvasive Detection, Staging, And Medical Monitoring Of Disease Progression | Non-Final OA | Exopharma, Inc |
| 17770807 | SAMPLE PREPARATION AND SEQUENCING ANALYSIS FOR REPEAT EXPANSION DISORDERS AND SHORT READ DEFICIENT TARGETS | Final Rejection | JumpCode Genomics, Inc. |
| 17757847 | METHOD OF DETECTING EPIGENETIC MODIFICATION | Final Rejection | Biofidelity Ltd |
| 17787114 | COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING A MYCOBACTERIUM TUBERCULOSIS INFECTION | Non-Final OA | San Diego State University (SDSU )Foundation, dba San Diego State University Research Foundation |
| 17309902 | METHYLATION MODIFICATION-BASED TUMOR MARKER STAMP-EP6 | Non-Final OA | SHANGHAI EPIPROBE BIOTECHNOLOGY CO., LTD. |
| 17714271 | METHOD FOR DETERMINING WHETHER BIOLOGICAL SAMPLE HASORIGINATED FROM LIVER CANCER TISSUE | Non-Final OA | LEPIDYNE CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy